| |
Home >
Business
>
Business
>
PREMIER Biosoft Completes Acquisition of Redasoft.
PREMIER Biosoft Completes Acquisition of Redasoft.
PREMIER Biosoft, a leading bioinformatics company, adds strength to its life Science Software Development Business with the acquisition of Redasoft.
Palo Alto,
California,
United States
(pr4links.com)
06/08/2011
Palo Alto, California – August 05, 2011, PREMIER Biosoft, a leading provider of software solutions for life science research, today announced the complete acquisition of Redasoft, a privately held company incorporated in California, USA and marketer of Visual Cloning, a popular sequence analysis software.
PREMIER Biosoft expects this strategic acquisition to accelerate its growth in life science software development by meeting the requirements of a wider customer base. As a result of this acquisition, PREMIER Biosoft now has a greater presence in targeted international markets where the company sees significant opportunities for growth.
“The acquisition of Redasoft demonstrates our strategy to strengthen our presence in the life science sector and deliver sustainable, industry-leading growth by offering a wide portfolio of products and services,” said Kay Brown, President, PREMIER Biosoft.
About PREMIER Biosoft
Founded in 1994, is a group of computer scientists and biologists dedicated to producing cutting edge intuitive software for research in life sciences. Our goal is to study the most recent innovations in life sciences and translate them into software products to aid research.
More information is available at http://www.PremierBiosoft.com.
Contact:
Arun Apte
PREMIER Biosoft
650-856-2703
http://www.PremierBiosoft.com
Email: support@premierbiosoft.com
About
About PREMIER Biosoft International:
Founded in 1994, is a group of computer scientists and biologists dedicated to producing cutting edge intuitive software for research in life sciences. Our goal is to study the most recent innovations in life sciences and translate them into software products to aid research.
More information is available at http://www.PremierBiosoft.com.
|